Ascletis Pharma Inc. (HKG:1672)

Ascletis Pharma Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 12, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	12,297	2,904	1,522	5,153	3,575	3,154
Market Cap Growth	434.68%	90.74%	-70.46%	44.13%	13.38%	-4.03%
Enterprise Value	10,328	665	-1,197	2,236	435	-134
Last Close Price	12.46	3.01	1.46	4.74	3.29	2.87
PS Ratio	4746.96	2126.81	24.42	84.27	37.89	75.87
PB Ratio	6.01	1.39	0.59	1.80	1.07	0.89
P/TBV Ratio	6.04	1.40	0.60	1.81	1.10	0.92
EV/Sales Ratio	-	486.91	-	36.57	4.61	-
Debt / Equity Ratio	0.00	0.00	0.00	0.00	0.00	0.00
Asset Turnover	0.00	0.00	0.02	0.02	0.03	0.01
Inventory Turnover	0.27	0.11	2.30	2.05	0.66	1.02
Quick Ratio	14.52	12.82	16.50	23.24	28.26	37.47
Current Ratio	14.57	12.88	16.58	23.52	28.93	38.36
Return on Equity (ROE)	-12.78%	-13.97%	-5.93%	-11.95%	-6.97%	-6.64%
Return on Assets (ROA)	-12.32%	-10.96%	-7.50%	-7.94%	-4.88%	-4.79%
Return on Capital (ROIC)	-12.96%	-11.70%	-7.89%	-8.26%	-5.04%	-4.93%
Return on Capital Employed (ROCE)	-22.50%	-20.50%	-13.10%	-13.70%	-8.40%	-8.30%
Earnings Yield	-2.30%	-11.03%	-10.47%	-6.91%	-6.83%	-7.88%
FCF Yield	-2.79%	-12.60%	-16.64%	-4.60%	-5.21%	-3.38%
Buyback Yield / Dilution	6.18%	6.75%	1.19%	0.96%	-5.53%	1.37%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.